TC BioPharm (Holdings) PLC - ADR

NEW
OTCPK:TCBPY (UK)   ADR
$ 0.25 +0.030 (+13.64%) 10:47 AM EST
At Loss
P/B:
1.92
Market Cap:
$ 127.00K
Enterprise V:
$ 962.00K
Volume:
58.99K
Avg Vol (2M):
512.58K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
58.99K
At Loss
Avg Vol (2M):
512.58K

Business Description

Description
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Name Current Vs Industry Vs History
Cash-To-Debt 0.61
Equity-to-Asset 0.29
Debt-to-Equity 0.83
Debt-to-EBITDA -0.32
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate 40.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.12
Quick Ratio 1.12
Cash Ratio 0.28

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 1.35

Profitability Rank

Name Current Vs Industry Vs History
ROE % -274.3
ROA % -68.16
ROIC % -136.89
3-Year ROIIC % 198.13
ROC (Joel Greenblatt) % -219.43
ROCE % -161.28

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 1.92
Price-to-Tangible-Book 2.78
EV-to-EBIT -0.14
EV-to-EBITDA -0.14
EV-to-Forward-Revenue 0.01
EV-to-FCF -11.18
Earnings Yield (Greenblatt) % -714.29
FCF Yield % -5184.25

Financials

TCBPY's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:TCBPY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

TC BioPharm (Holdings) PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -529.043
Beta 0.1
3-Year Sharpe Ratio -2.55
3-Year Sortino Ratio -2.16
Volatility % 105.15
14-Day RSI 17.27
14-Day ATR ($) 0.404562
20-Day SMA ($) 1.3205
12-1 Month Momentum % -99.07
52-Week Range ($) 0.08 - 523.2
Shares Outstanding (Mil) 0.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TC BioPharm (Holdings) PLC Filings

Filing Date Document Date Form
No Filing Data

TC BioPharm (Holdings) PLC Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

TC BioPharm (Holdings) PLC Frequently Asked Questions

What is TC BioPharm (Holdings) PLC(TCBPY)'s stock price today?
The current price of TCBPY is $0.25. The 52 week high of TCBPY is $523.20 and 52 week low is $0.08.
When is next earnings date of TC BioPharm (Holdings) PLC(TCBPY)?
The next earnings date of TC BioPharm (Holdings) PLC(TCBPY) is .
Does TC BioPharm (Holdings) PLC(TCBPY) pay dividends? If so, how much?
TC BioPharm (Holdings) PLC(TCBPY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1